Teflaro is a Intravenous Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Ceftaroline Fosamil.
| Product ID | 0456-0600_0125d943-1b18-45f9-971f-4ee704ec54b7 |
| NDC | 0456-0600 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Teflaro |
| Generic Name | Ceftaroline Fosamil |
| Dosage Form | Powder, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2010-10-29 |
| Marketing Category | NDA / NDA |
| Application Number | NDA200327 |
| Labeler Name | Allergan, Inc. |
| Substance Name | CEFTAROLINE FOSAMIL |
| Active Ingredient Strength | 600 mg/20mL |
| Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2010-10-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA200327 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-10-29 |
| Marketing Category | NDA |
| Application Number | NDA200327 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-10-29 |
| Ingredient | Strength |
|---|---|
| CEFTAROLINE FOSAMIL | 600 mg/20mL |
| SPL SET ID: | 3ecde48b-75a2-4beb-9999-369f3f61bb8a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0456-0400 | Teflaro | ceftaroline fosamil |
| 0456-0600 | Teflaro | ceftaroline fosamil |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TEFLARO 85073011 3949340 Live/Registered |
ALLERGAN SALES, LLC 2010-06-28 |
![]() TEFLARO 85018295 3935814 Live/Registered |
ALLERGAN SALES, LLC 2010-04-20 |